Paul is an experienced, UK-based pharmaceutical research and development professional who has worked in biotechnology and pharmaceutical industries since 2001. During this time he gained experience of Big Pharma, Specialty Pharma and Start-ups, including GlaxoSmithKline, Q Chip Ltd, Immaterial Ltd and Midatech Pharma PLC. He has managed multi-disciplinary drug development teams and led the pharmaceutical development of drug products from bench to clinic.
Holding a degree in Biotechnology and a PhD in Pharmaceutical Microbiology Paul has developed expertise in drug delivery. He previously held the role of VP Pharmaceutical & Technology Development at Midatech Pharma PLC, with responsibility for all formulation and CMC aspects across three drug delivery technologies. Paul has expertise in conceptualisation and development of novel, complex formulations and drug products, with a focus on novel, non-standard manufacturing processes. He is named inventor on 7 patent families and is author on a number of original publications in the fields of pharmaceutical microbiology, drug delivery and pharmaceutical process design.
Paul has an established network with CROs and CDMOs across the UK, EU and US. He is experienced in writing regulatory documents (including CMC sections of IMPD, CTA, IND, ODD) and has had regular direct contact with numerous regulatory agencies (including MHRA, EMA, BfARM, SwissMedic and US FDA). He is an active member of the Parenteral Drug Association, Royal Society of Biology and Controlled Release Society.